Jaipur, Sept. 22 -- The Bharatiya Janata Party (BJP) secured the Deputy Mayor posts in Bikaner and Ajmer Municipal Corporations following the results being declared of the closely contested elections.... Read More
New York, Sept. 22 -- General Secretary of the Communist Party of Vietnam Central Committee and President To Lam, together with the high-ranking Vietnamese delegation, attended a cultural event and me... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'Characteristics and durability of immune response to fractional dose compared to standard dose Ye... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety an... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'The use of Landiolol in mitral valve sUrgery: a raNdomized, controlled, double-blind triAl. (LUNA... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations'. ... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or ... Read More
Singapore, Sept. 22 -- The Health Sciences Authority received information related to the study titled 'An Interventional, Open-Label, Phase 2 Study to Investigate the Safety and Efficacy of PF-0863440... Read More